Nucor Slashes Profit Expectations: What You Need to Know
Nucor cut its quarterly profit forecast to $2.05-$2.15/share, down from $2.60. All segments face lower volumes, margins, or higher costs.
Nucor cut its quarterly profit forecast to $2.05-$2.15/share, down from $2.60. All segments face lower volumes, margins, or higher costs.
Google & PayPal team up! They're blending PayPal's payments with Google's AI to create new "agentic commerce" where AI agents shop for you. This partnership aims to redefine future shopping experiences.
The "Wegovy in a pill" (oral semaglutide 25 mg) shows huge promise for weight loss! Patients lost an average of 16.6% body weight, comparable to the injection. It's the first oral GLP-1 for weight management, offering convenience, and awaits FDA approval.
Bullish Q2 earnings crushed estimates with $108.3M profit & $179.6B trading volume. They secured the NY Bitlicense, boosting global reach. Q3 looks strong.
Reddit is seeking new AI deals with Google & OpenAI for "dynamic pricing," wanting more value for its valuable, user-generated data used to train AI. They hope to convert Google traffic into active users and are already set to earn $203M from existing deals.
Garetosmab is a new drug for FOP, a rare disease where muscles turn to bone. In trials, it dramatically cut new abnormal bone growth by over 90%. This could be a major breakthrough, and Regeneron aims for U.S. approval by late 2025.